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Abstract
Background: This study examined phenomenological manifestations of delirium in advanced cancer patients by
examining the factor structure of the Delirium Rating Scale-Revised-98 (DRS-R-98) and profiles of delirium symptoms.
Methods: Ninety-three patients with advanced cancer admitted to inpatient palliative care units in South Korea were
examined by psychiatrists using the DRS-R-98 and the Confusion Assessment Method (CAM). The factor structure of
the DRS-R-98 was examined by exploratory structural equation modelling analysis (ESEM) and profiles of delirium were
examined by latent profile analysis (LPA).
Results: CAM-defined delirium was present in 66.6% (n = 62) of patients. Results from the ESEM analysis
confirmed applicability of the core and noncore symptom factors of the DRS-R-98 to advanced cancer patients.
LPA identified three distinct profiles of delirium characterizing the overall severity of delirium and its core and
noncore symptoms. Class 1 (n = 55, 59.1%) showed low levels of all delirium symptoms. Class 2 (n = 17, 18.3%)
showed high levels of core symptoms only, whereas Class 3 (n = 21, 22.6%) showed high levels of both core and
noncore symptoms except motor retardation.
Conclusions: Clinical care for delirium in advanced cancer patients may benefit from consideration of the core
and noncore symptom factor structure and the three distinct phenomenological profiles of delirium observed in
the present study.
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Background
Delirium in palliative care, especially in an inpatient
palliative care setting, is a more serious and prevalent
concern. A recent systematic review and meta-analysis
indicated that up to 74% of patients experience delirium
in inpatient palliative care units and its prevalence goes
up to 88% approaching death. Pooled prevalence estimates
indicated that one third of patients were diagnosed with
delirium at the time of admission to inpatient palliative
care [1]. This high prevalence reflects that patients in pal-
liative care settings are more frail, with poor performance
status [2]. It was suggested that delirium-induced disinhib-
ition may result in the overexpression and worsening of
physical and psychological symptoms [3]. It also affects
survival length [2], and it distresses the family members of
terminal cancer patients [4].
An examination of the phenomenology of delirium in
advanced cancer patients with a valid assessment tool is
the first step to relieve such a burden. To this end,
several assessment tools for delirium have been applied
in palliative care settings. The Confusion Assessment
Method [5] and the Memorial Delirium Assessment
Scale (MDAS) [6] are commonly used and serve as the
recommended assessment tools in palliative care [7, 8].
The Delirium Rating Scale-Revised-98 (DRS-R-98) [9],
which was developed based on theory and clinical experi-
ences [10], is another important assessment tool, and it is
considered to be the most detailed phenomenological tool
available, allowing both the diagnosis of delirium and
detailed assessments of the severity of its symptoms [11].
The applicability of the DRS-R-98 in palliative care
settings was partly demonstrated by its good overall
agreement with the MDAS [12]. Yet, as a previous
review indicated, there have been no validity examina-
tions for the DRS-R-98 in the palliative care setting [13],
and in particular, limited studies examining its construct
validity with advanced cancer patients.
On the other hand, the validity of the DRS-R-98 has
been examined in other patient populations and settings.
In particular, the factor structure of the DRS-R-98 has
been the subject of previous examinations with some
varying results regarding the number of factors, mostly
indicating either two [14, 15] or three factors [16, 17].
For instance, Franco et al. [14] identified the “Cognition,
and Psychosis/Agitation factors” in a study with 161 sur-
gical patients, and Jain et al. [15] proposed the cognitive,
and behavioral factors in their study with 86 referred
patients with delirium. On the other hand, Grover et al.
[16] and Matoo et al. [17], in their studies with patients
with confirmed diagnoses of delirium, proposed three
factors for the DRS-R-98: “global cognitive,” “sleep and
motor symptoms,” and the “thought and language” fac-
tors for the first; and “cognition”; “circadian & psychosis,
” and “higher order thinking” factors for the latter. A
factor structure similar to that suggested by Matoo et al.
[17] was also observed in a study by Franco et al. [18].
Using a pooled international dataset of 592 patients, they
proposed that the core symptoms of delirium as assessed
by the DRS-R-98 is consisted of three core domains:
circadian, cognitive, and higher level thinking. All these
findings appear to be somewhat synthesized into the two
factor structure of the DRS-R-98, i.e., the core and non-
core symptom factors proposed by the latest examin-
ation with the data from 859 adult patients in a multisite
pooled international delirium database by Thurber et al.
[10]. Core symptoms such as disturbances in attention
and other cognitive functions represent common and
consistent features of delirium, whereas noncore symp-
toms represent less common and more variable features
of delirium such perceptual disturbances or lability of
affect [18].
In view of this, the present study aimed to examine
whether the core and noncore factors proposed by
Thurber et al. [10] is applicable to advanced cancer
patients in an attempt to explore the phenomenology of
delirium as observed in advanced cancer patients [15].
In so doing, the present study applied the exploratory
structural equation modeling (ESEM) method, which is
an integration of confirmatory factor analysis (CFA), ex-
ploratory factor analysis, and structural equation model-
ing [19]. It has been suggested that as clinical symptoms
tend to be correlated, the CFA requirement of the re-
striction of zero cross-loadings might be restrictive, lead-
ing to potentially biased estimates [19, 20]. When non-
zero cross-loadings are specified as zero as in the CFA,
it may lead to over-estimated factor correlations and
subsequent distorted structural relations. For this reason,
it was considered important to extend structural equa-
tion modeling to permit less restrictive measurement
models that can be used together with the CFA models,
which is ESEM [21]. ESEM is considered to be appropri-
ate in clinical studies in which traditional factor analyses
may not be appropriate [19].
In addition, the present study examined profiles of
delirium symptoms through latent profile analysis, a
person-centered approach that identifies homogenous
subgroups of individuals based on the pattern of the
means of observed variables, i.e., individual delirium
symptoms as assessed by the DRS-R-98 in the present
study [22]. Understanding of subgroups of patients who
share similar patterns of delirium symptoms may allow
for a tailored approach to interventions in advanced
cancer patients with delirium.
Therefore, the present study examined phenomeno-
logical manifestations of delirium by examining the
factor structure of the DRS-R-98 and profiles of delir-
ium symptoms in advanced cancer patients receiving
palliative care.
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Methods
Participants and procedures
Patients were consecutively recruited from two inpatient
palliative care units in South Korea between August
2018 to July 2019. Attending psychiatrists in these 2
units assessed delirium symptoms of admitted patients
using the DRS-R-98 and the Confusion Assessment
Method (CAM) upon obtaining informed consent. A
total of 93 patients were assessed, of which 73 patients
were from the palliative care unit of a university hospital,
and 20 patients were from the palliative care unit in a
provincial medical center. This study was approved by
two Institutional Review Boards (IRB No. H-1809-105-
974, and IRB No. 2018–07-006).
Measures
The DRS-R-98 is a composed of 13 items assessing the
severity of delirium symptoms and 3 diagnostic items
(i.e., temporal onset, fluctuation of symptoms, and phys-
ical disorder) [9]. Severity items include the sleep-wake
cycle, perceptual disturbances, delusions, lability of
affect, language, thought process, motor agitation or
retardation, orientation, attention, and short- and long-
term memory, and visuospatial ability. Symptoms are
rated on a four-point scale (0–3) with a score range of 0
to 39. A severity scores of over 15 is considered to be a
case of delirium. The Cronbach’s alpha of the DRS-R-98
total and severity scale were 0.90 and 0.87, respectively,
and the interrater reliability (the intraclass coefficient)
ranged from 0.98 to 0.99 [9].
The CAM was also administered to define the diagnosis
of delirium. The CAM has 9 items, four of which are
diagnostic items (i.e., acute onset, inattention, disorganized
thinking, and altered level of consciousness) [5]. The inter-
rater reliability of the CAM (kappa) was between 0.81 to
1.0 [5].
Statistical analyses
The two-factor structure (i.e., core and noncore symp-
toms of delirium) of the DRS-R-98 was examined by the
ESEM, and model-fit indices were examined. The cri-
teria to evaluate the goodness-of-fit indices of the model
were the following: root mean square error of approxi-
mation (RMSEA) ≤ .08, 90% confidence interval (CI) of
RMSEA; comparative fit index (CFI) ≥ .95; Tucker-Lewis
Index (TLI) ≥ .95; and standardized root mean square
residual (SRMR) ≤ .08 [23].
Patterns of delirium symptoms were examined by latent
profile analysis (LPA) [22]. Thirteen severity symptoms of
the DRS-R-98 were used as indicators. To determine the
optimal number of latent classes, three information criter-
ion indices (i.e., Akaike Information Criterion, AIC; Bayes-
ian Information Criterion, BIC; and sample-size-adjusted
BIC, SA-BIC) were evaluated with smaller values of the all
these indices indicating the better model fit [24]. The
classification accuracy was evaluated by the entropy with
the larger value indicating a better accuracy [25], and its
values above 0.80 were considered adequate [26]. Lastly,
the Lo-Mendell-Rubin likelihood ratio test (LMR) [27] and
bootstrap likelihood ratio test (BLRT) [24] were examined
to determine whether a k profile solution fits better than a
k − 1 profile solution. A significant value p-value indicates
a fit improvement with the addition of the class [24].
Predictors of the latent class membership were exam-
ined using multinomial logistic regression analyses with
R3STEP method [28]. Statistical analyses were performed
using the IBM SPSS statistical package (version 25.0) and
the Mplus software (version 8.3).
Potential differences between the classes in the total
and severity scores of the DRS-R-98, and the core and
noncore symptoms was examined by the analysis of
variance (ANOVA).
Results
Participant characteristics and symptoms of delirium
A total of 93 patients with advanced cancer receiving
palliative were examined, and their sociodemographic
characteristics are shown in supplementary Table 1. The
majority of patients were male (52, 57.1%) and married
(65, 73.9%). Delirium as diagnosed by the CAM criteria
was present in 66.6% (n = 62). The delirium and non-
delirium groups significantly differed in terms of age
(72.9 versus 66.6; t = 2.28, p < .05) and hospitalization
period (9 days versus 2.5 days; t = 3.15, p < .01).
Means and frequency of individual delirium symp-
toms, the means of the DRS-R-98 total, and severity
scores of the patients are shown in Table 1. The total
and severity scores were higher in the delirium group
than in the non-delirium group (22.343 vs 5.23 for total
scores, t = 13.42, p < .001; 17.46 vs 2.65 for severity
scores, t = 12.20, p < .001).
Factor structure of the DRS-R-98
Examination of the two factor structure (i.e., core and
noncore symptoms of delirium) applied to ESEM yielded
an adequate fit for the model (Χ2(73) = 134.8, p < .001;
RMSEA = .095 [.070–.120]; CFI = .951; TLI = .930; and
SRMR = .037). Two diagnostic items (i.e., temporal onset
and fluctuation of symptoms), and the core symptoms
(i.e., sleep wake cycle, language, thought process, motor
retardation, orientation, attention, short-term and long-
term memory, and visuospatial ability) were loaded on
the factor 1, and the noncore symptoms (i.e., perceptual
disturbances, delusions, lability of affect, and motor
agitation) were loaded on the factor 2 (Table 2). The
correlation between factors 1 and 2 was .44.
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Profiles of delirium symptoms
Results of the latent profile analysis indicated that the
models converged up to three classes (Table 3). The
three-class solution was deemed to be the best based on
an overall examination of model fit indices. Three
profiles of delirium symptoms are depicted in Fig. 1 and
supplementary Table 2. The classes were characterized
by the overall severity of delirium as well as severity of
the core and noncore symptoms. Class 1 (n = 55, 59.1%)
was characterized by low levels of all delirium symp-
toms. Class 2 (n = 17, 18.3%) was characterized by its
high levels of core delirium symptoms only, whereas
Class 3 (n = 21, 22.6%) showed high levels of both core
and noncore symptoms except the motor retardation.
The ANOVA results indicated that Classes 2 and 3
significantly differed only in the level of noncore symp-
toms, F = 108.41, p < .001, M = 1.5 (SD = 1.8) vs 7.6 (SD =
2.3), respectively, but not in core symptoms or total and
Table 1 DRS-R-98 items means and frequencies (N = 93)
Total (N = 93) Delirium (n = 62) No Delirium (n = 31)












1. Sleep-wake cycle 78.5 1.56 (1.08) 93.5 2.06 (.88) 48.4 .55 (.62)
2. Perceptual disturbances 40.2 .79 (1.14) 60.7 1.20 (1.22) 0.0 .00 (.00)
3. Delusions 22.8 .36 (.74) 34.4 .54 (.85) 0.0 .00 (.00)
4. Lability of affect 35.5 .57 (.88) 50.0 .79 (.93) 6.5 .13 (.56)
5. Language 49.5 .86 (1.06) 74.2 1.29 (1.06) 0.0 .00 (.00)
6. Thought process 62.4 1.04 (1.02) 88.7 1.48 (.90) 9.7 .16 (.58)
7. Motor agitation 47.3 .87 (1.12) 62.9 1.23 (1.19) 16.1 .16 (.37)
8. Motor retardation 40.9 .73 (1.05) 48.4 .97 (1.19) 25.8 .26 (.44)
9. Orientation 64.1 1.33 (1.23) 88.5 1.89 (1.08) 16.1 .23 (.62)
10. Attention 79.6 1.45 (1.08) 100.0 1.98 (.88) 38.7 .39 (.50)
11. Short-term memory 71.7 1.27 (1.07) 90.2 1.70 (.97) 35.5 .42 (.67)
12. Long-term memory 43.5 .70 (.92) 57.4 .93 (.96) 16.1 .23 (.62)
13. Visuospatial ability 54.3 1.02 (1.16) 78.7 1.48 (1.12) 6.5 .13 (.56)
14. Temporal onset 81.7 1.46 (.80) 100.0 1.94 (.31) 45.2 .52 (.63)
15. Fluctuation of symptom 68.8 .71 (.50) 100.0 1.03 (.18) 6.5 .06 (.25)
16. Physical disorder 100.0 2.00 (.00) 100.0 2.00 (.00) 100.0 2.00 (.00)
DRS-R-98 Severity score 12.47 (9.99) 17.46 (8.45) 2.65 (3.06) ***
DRS-R-98 Total score 16.63 (10.93) 22.43 (8.53) 5.23 (3.74) ***
Note. *** p < .001
Table 2 Factor loading matrix of the ESEM model of DRS-R-98
(N = 93)
DRS-R-98-item Factor 1 Factor 2
1. Sleep-wake cycle .69*** .29***
2. Perceptual disturbances .18* .64***
3. Delusions .19* .50***
4. Lability of affect −.03 .75***
5. Language .87*** −.08
6. Thought process .70*** .24***
7. Motor agitation .17* .69***
8. Motor retardation .69*** −.35***
9. Orientation .90*** .09
10. Attention .70*** .31***
11. Short-term memory 1.00*** −.20**
12. Long-term memory .95*** −.35***
13. Visuospatial ability .91*** −.08
14. Temporal onset of symptom .59*** .21*
15. Fluctuation of symptom .50*** .33***
Note. Factor loading of > .40 are bolded;
* p < .05, ** p < .01, *** p < .001
Table 3 Fit indices for latent profile analysis models
Model AIC BIC SABIC LMRLRT (p) BLRT (p) Entropy
1-class 3532.36 3598.20 3516.13
2-class 2827.82 2929.12 2802.85 .000 .000 1
3-class 2632.72 2769.48 2599.01 .258 .000 .992
Notes. AIC Akaike information criteria, BIC Bayesian information criteria, SABIC
Sample-size adjusted BIC, LMRLRT Lo, Mendell, & Rubin (2001) test, BLRT
Bootstrapped log-likelihood ratio test
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severity scores (Fig. 2). The percentage of patients with
CAM defined delirium was 45.5% (25/55), 94.1% (16/17),
and 100% (21/21) for Classes 1, 2 and 3, respectively.
The results of multinomial logistic regression analysis
indicated that only the length of hospitalization signifi-
cantly predicted the class membership (Table 4).
Patients with a longer hospitalizations were more likely
to be in Class 2 than in Class 3 (OR = 1.127; p < .05), or




The present study examined phenomenological manifes-
tations of delirium symptoms in 93 advanced cancer
patient from two inpatient palliative care units in South
Korea. Specifically, the core and noncore symptom
factor structure of the DRS-R-98 suggested by Thurber
et al. [10] was examined. Moreover, patterns of delirium
symptoms were examined by latent profile analysis.
The results of the ESEM supported the two previously
observed separate but correlated factors of delirium, i.e.,
the core and noncore symptoms of delirium [10]. A
single factor comprised of core symptoms concurs with
the previous EFA results including only core symptoms
which were the circadian, higher level thinking, and
cognitive symptoms [18].
Consistent with the loading pattern previously ob-
served, two diagnostic items and core symptoms were
loaded on factor 1 whereas noncore symptoms were
loaded on factor 2 [10]. Regarding the loading of the
motor agitation on the noncore symptoms, Thurber
et al. [10] suggested that while a motor agitation (i.e.,
hyperactivity) is a component of circadian rhythm, it
may also be affected by similar neurophysiological mech-
anisms (e.g., excess of dopaminergic activity) behind
noncore symptoms.
Fig. 1 Latent profiles of delirium symptoms
Fig. 2 The DRS-R-98 total and severity scores and the core and noncore symptoms among the classes. Class 1: Low on all symptoms (n = 55);
Class 2: High only on core symptoms (n = 17); Class 3: High on all symptoms (n = 21)
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Yet, the magnitude of loadings of specific symptoms in
the core symptom factors slightly differed, and memory
deficits (i.e., short- and long-term) had high loadings in
contrast to the previous findings indicating the highest
loading of attention on the core symptoms [10]. Memory
deficits are quite common in the phenomenology of
delirium with the rates of 88–96% [29]. In fact, the
occurrence of short- and long-term memory deficits (88
and 89%, respectively) was the second highest after those
of attention and sleep wake cycle disturbances, both of
which were 97% in severity according to a previous as-
sessment of 100 delirium cases [30]. Short-term memory
impairment was also prevalent as a moderate to severe
degree of impairment was observed in 90% of cancer
patients with delirium [31]. Attention deficit, an essential
diagnostic criterion, was a prominent symptom in Classes
2 and 3, in which almost all patients had the delirium,
confirming that it is a cardinal feature of delirium.
Apart from sleep-wake cycle disturbances, the non-
core symptom factors in the present study concurs
with the “sleep and motor symptom” factor in the
previous finding with 151 delirium patients [16] and
the “behavioral” factor proposed in a study with 86
referred patients [15].
The core and noncore symptom factors seemed to be
reflected in the LPA results. Latent profile analysis with
individual symptoms from the DRS-R-98 identified the
three distinct classes. These classes were characterized
by the overall severity of delirium as well as the severity
of the core and noncore symptoms. Class 1 showed low
levels of all delirium symptoms. Class 2 showed high
levels of core delirium symptoms but not noncore symp-
toms, whereas the Class 3 showed high levels of both
core and noncore symptoms except motor retardation.
The ANOVA results confirmed that Classes 2 and 3
significantly differed only in their levels of noncore
symptoms. With regard to motor symptoms, Classes 2
and 3 showed opposite patterns. While motor retard-
ation was at its peak in Class 2, motor agitation peaked
in Class 3. It may be that these classes reflect hypoactive
and hyperactive or mixed subtypes of delirium.
The length of hospitalization was a significant pre-
dictor of the class membership, and a longer length of
stay was generally associated with the classes having a
greater severity of delirium.
Clinical implications
The DRS-R-98 is known to be developed based on clin-
ical presentations of symptoms in patients with delirium
which are not sufficiently reflected in the DSM-IV diag-
nostic criteria [10]. The current examinations supported
previously observed and distinct presentations of the
core and noncore symptoms of delirium [10]. Along
with the overall severity of delirium, the severity of core
and noncore symptoms characterized three latent
profiles of delirium, which suggest that it may be helpful
to examine not only the total scores but also patterns of
core and noncore symptoms.
Adequate assessment and subsequent treatment of
core symptoms are important as the core symptoms in
orientation, short- and long-term memory, attention,
and thought processes prominently characterized per-
sistent delirium in a longitudinal examination of patients
with delirium admitted to a palliative care unit [32].
Similarly, the severity of long-term memory during the
delirium episode was associated with a longer duration
of delirium in a previous longitudinal examination [33].
The evaluation of noncore symptoms serves its purpose
in the clinical management of delirium. For instance, non-
core symptoms such as perceptual disturbances, lability of
affect, and motor agitation were among the symptoms
that distinguished both delirium and prodromal delirium
from non-delirium in a study of 161 surgical patients [14].
Moreover, the noncore symptoms from the DRS-R-98
differed between patients with a mixed subtype and those
with a hypoactive subtype in a study with 321 referred
patients to a consultation-liaison psychiatric consultation
[34], and in particular, the occurrence and severity of
Table 4 Predictors of the class membership
Class 1 vs. Class 2a Class 1 vs. Class 3a Class 2 vs. Class 3a
Predictors Coef. SE OR Coef. SE OR Coef. SE OR
Age .013 .033 1.013 −.029 .031 .972 −.041 .043 .960
Sex −.475 .657 .622 −.032 .758 .968 .443 .931 1.557
Education .949 1.089 2.583 −.442 .518 .643 −1.391 1.250 .249
Marital status .106 .687 1.111 .478 .770 1.613 .373 .931 1.452
Religion .384 .742 1.467 −1.065 .616 .345 −1.448 .915 .235
Hospitalization period (days) −.044* .019 .957 .075 .057 1.078 .120* .056 1.127
Notes. aReference group; Class 1: low on all symptoms; Class 2: high only on core symptoms; Class 3: high on all symptoms; Coef. the estimate (β) from the R3STEP
multinomial logistic regression; SE Standard error of the coefficient, OR Odds ratio; Analyses were conducted with the data from 86 patients due to
listwise deletion
* p < .05
Shim et al. BMC Palliative Care          (2020) 19:162 Page 6 of 8
perceptual disturbances and delusions differed between
the hyperactive and hypoactive subtypes of delirium in a
study with 100 cancer patients [35]. Hypoactive and mixed
subtypes of delirium are known to be common in pallia-
tive care patients, and one review indicated that hypoac-
tive delirium is the most prevalent subtype of delirium in
palliative care [36]. As the hypoactive type is associated
with persistent delirium [37], and increased mortality [38],
its prompt recognition is important. Still, the misdiagnosis
of the hypoactive subtype of delirium as depression or
fatigue often occurs in palliative care patients at the ter-
minal stage [7]. These findings suggest that assessment of
noncore symptoms may be useful for the early detection
of full delirium as well as correct diagnosis of delirium.
Taken together, the current findings suggest the need
for tailored management of delirium with advanced
cancer patients in the palliative care settings, considering
differences in the phenomenological manifestations of
delirium.
Limitations
This study has several limitations. A relatively small
sample size may have affected the statistical power of
analyses such as ESEM and LPA, as well as the
generalizability of the findings. Moreover, although a
previous study suggests that the phenomenology of the
DRS–R-98 was not different with or without comorbid
cognitive impairment in patients with delirium [30], in-
formation about comorbidities such as dementia, depres-
sion, and other psychiatric or physical conditions, which
may have affected phenomenological manifestations of
delirium, were unavailable in this study. Moreover, in
the absence of information, clinical characteristics (e.g.,
cancer stage and performance status) associated with
class membership as well as the potential impact of
identified profiles of delirium on outcomes such as
mortality or patient reported outcomes could not be
examined. Furthermore, this study did not examine
different subtypes of delirium, which may have helped to
better understand the classes identified in this study.
Conclusions
Nonetheless, the present study attempted the phenom-
enological examination of delirium as experienced in
advanced cancer patients, applying analytic methods
such as the exploratory structural equation modelling,
which may be more suitable for studying clinical condi-
tions such as delirium, and latent profile analysis, a
person-centered analytical approach which allowed the
identification of three subgroups of patients based on
their patterns of individual delirium symptoms.
Clinical care for the highly distressing condition of
delirium prevalent in advanced cancer patients may
benefit from the consideration of the core and noncore
symptom factor structure and the three distinct phenom-
enological profiles of delirium observed in the present
study.
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